Inhibiting VDAC1 oligomerization attenuated cerebral ischemia-reperfusion injury by promoting mitophagy via reduced

Xiangna Guo1, Huiyi Jiang2, Yitian Lu3

  • 1Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, 510060, China; Department of Anesthesiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, 510510, China; Department of Sleep and Brain Medicine Center, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, 518000, China.

Insights

Inhibiting voltage-dependent anion channel 1 (VDAC1) oligomerization protects the brain from ischemic stroke by enhancing mitophagy, reducing damage, and improving neurological function.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Mitochondrial Biology

Background:

  • Mitophagy is crucial for removing damaged mitochondria during ischemic stroke.
  • Voltage-dependent anion channel 1 (VDAC1) acts as a gatekeeper for mitophagy.
  • The role of VDAC1 in cerebral ischemia-reperfusion (I/R) injury is not well understood.

Purpose of the Study:

  • To investigate the role of VDAC1 in cerebral I/R injury.
  • To explore the underlying mechanisms by which VDAC1 influences mitophagy and neuroprotection.

Main Methods:

  • Inhibition of VDAC1 oligomerization in a cerebral I/R injury model.
  • VDAC1 knockdown in neurons subjected to oxygen-glucose deprivation/reoxygenation (OGD/R).
  • Assessment of infarct volume, neurological function, mitophagy, mitochondrial membrane potential, and reactive oxygen species (ROS) generation.
  • Identification of interacting proteins using co-immunoprecipitation.

Main Results:

  • Inhibiting VDAC1 oligomerization reduced infarct volume and improved neurological outcomes after cerebral I/R.
  • Promoting mitophagy via VDAC1 inhibition conferred neuroprotective effects.
  • VDAC1 knockdown preserved mitochondrial membrane potential and decreased ROS production in OGD/R-treated neurons.
  • The interaction between VDAC1 oligomers and Lon protease 1 (LONP1) was identified as a key regulator of mitophagy.

Conclusions:

  • VDAC1 oligomerization plays a significant role in cerebral I/R injury.
  • Targeting VDAC1 oligomerization enhances mitophagy and offers neuroprotection.
  • VDAC1 is a potential therapeutic target for treating ischemic stroke.